The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Upregulation of β3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium
Open accessAbstract
Background—Contrary to β 1- and β 2-adrenoceptors, β 3-adrenoceptors mediate a negative inotropic effect in human ventricular muscle. To assess their functional role in heart failure, our purpose was to compare the expression and contractile effect of β 3-adrenoceptors in nonfailing and failing human hearts. Methods and Results—We analyzed left ventricular samples from 29 failing (16 ischemic and 13 dilated cardiomyopathic) hearts (ejection fraction 18.6±2%) and 25 nonfailing (including 12 innervated) explanted hearts (ejection fraction 64.2±3%). β 3-Adrenoceptor proteins were identified by immunohistochemistry in ventricular cardiomyocytes from nonfailing and failing hearts. Contrary to β 1-adrenoceptor mRNA, Western blot analysis of β 3-adrenoceptor proteins showed a 2- to 3-fold increase in failing compared with nonfailing hearts. A similar increase was observed for Gα i-2 proteins that couple β 3-adrenoceptors to their negative inotropic effect. Contractile tension was measured in electrically stimulated myocardial samples ex vivo. In failing hearts, the positive inotropic effect of the nonspecific amine isoprenaline was reduced by 75% compared with that observed in nonfailing hearts. By contrast, the negative inotropic effect of β 3-preferential agonists was only mildly reduced. Conclusions—Opposite changes occur in β 1- and β 3-adrenoceptor abundance in the failing left ventricle, with an imbalance between their inotropic influences that may underlie the functional degradation of the human failing heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Molecular Characterization of the Human β 3 -Adrenergic Receptor
Emorine, L. J., Marullo, S., Briend-Sutren, M.-M., Patey, G., Tate, K., Delavier-Klutchko, C., & Strosberg, A. D. (1989) · Science · doi:10.1126/science.2570461 · Cited by 1,088
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
Engelhardt, S., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 785
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Self-citationBrodde, O. E. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06662-1 · Cited by 572
Tissue distribution of beta 3-adrenergic receptor mRNA in man
Krief, S., Lönnqvist, F., Raimbault, S., Baude, B., Van Spronsen, A., Arner, P., Strosberg, A. D., Ricquier, D., & Emorine, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116191 · Cited by 528
Lowes, B. D., Minobe, W., Abraham, W. T., Rizeq, M. N., Bohlmeyer, T. J., Quaife, R. A., Roden, R. L., Dutcher, D. L., Robertson, A. D., Voelkel, N. F., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119770 · Cited by 503
Functional beta3-adrenoceptor in the human heart.
Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., & Le Marec, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118823 · Cited by 461
Self-citationLaborda, J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3998 · Cited by 427
Gauthier, C., Leblais, V, Kobzik, L., Trochu, J. N., Khandoudi, N., Bril, A., Balligand, J. L., & Le Marec, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2191 · Cited by 397
Self-citationBristow, M. R., Hershberger, R. E., Port, J. D., Minobe, W., & Rasmussen, R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11117-6 · Cited by 381
Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac G sα Overexpression
Iwase, M., Bishop, S. P., Uechi, M., Vatner, D. E., Shannon, R. P., Kudej, R. K., Wight, D. C., Wagner, T. E., Ishikawa, Y., Homcy, C. J., et al. (1996) · Circulation Research · doi:10.1161/01.res.78.4.517 · Cited by 267
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
Bristow, M. R., Minobe, W. A., Raynolds, M. V., Port, J. D., Rasmussen, R., Ray, P. E., & Feldman, A. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116891 · Cited by 238
Liggett, S. B., Freedman, N. J., Schwinn, D. A., & Lefkowitz, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3665 · Cited by 234
The Molecular Basis for Distinct β-Adrenergic Receptor Subtype Actions in Cardiomyocytes
Steinberg, S. F. (1999) · Circulation Research · doi:10.1161/01.res.85.11.1101 · Cited by 228
Hare, J. M., Loh, E., Creager, M. A., & Colucci, W. S. (1995) · Circulation · doi:10.1161/01.cir.92.8.2198 · Cited by 218
Eschenhagen, T., Mende, U., Nose, M., Schmitz, W., Scholz, H., Haverich, A., Hirt, S., Döring, V, Kalmár, P., & Höppner, W. (1992) · Circulation Research · doi:10.1161/01.res.70.4.688 · Cited by 213
Akhter, S. A., Skaer, C. A., Kypson, A. P., McDonald, P. H., Peppel, K. C., Glower, D. D., Lefkowitz, R. J., & Koch, W. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12100 · Cited by 194
β3-Adrenoceptors in the cardiovascular system
Gauthier, C., Langin, D., & Balligand, J.-L. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01562-5 · Cited by 187
Self-citationModulation of mouse cardiac function in vivo by eNOS and ANP
Gyurko, R., Kuhlencordt, P., Fishman, M. C., & Huang, P. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.3.h971 · Cited by 163
Hare, J. M., Givertz, M. M., Creager, M. A., & Colucci, W. S. (1998) · Circulation · doi:10.1161/01.cir.97.2.161 · Cited by 163
Endomyocardial Nitric Oxide Synthase and Left Ventricular Preload Reserve in Dilated Cardiomyopathy
Heymes, C., Vanderheyden, M., Bronzwaer, J. G. F., Shah, A. M., & Paulus, W. J. (1999) · Circulation · doi:10.1161/01.cir.99.23.3009 · Cited by 157
β3-adrenoceptor deficiency blocks nitric oxide–dependent inhibition of myocardial contractility
Varghese, P. J., Harrison, R. W., Lofthouse, R. A., Georgakopoulos, D., Berkowitz, D. E., & Hare, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9323 · Cited by 144
Engelhardt, S. H., Böhm, M., Erdmann, E., & Lohse, M. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00425-4 · Cited by 138
Chamberlain, P., Jennings, K., Paul, F., Cordell, J., Berry, A., Holmes, S., Park, J., Chambers, J., Sennitt, M. V., Stock, M. J., et al. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0801039 · Cited by 127
Lohse, M. J., Lefkowitz, R. J., Caron, M. G., & Benovic, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3011 · Cited by 122
Böhm, M., Eschenhagen, T., Gierschik, P., et al. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1017 · Cited by 120
Port, J. D., Gilbert, E. M., Larrabee, P. S., Mealey, P. C., Volkman, K., Ginsburg, R., Hershberger, R. E., Murray, J., & Bristow, M. R. (1990) · Circulation · doi:10.1161/01.cir.81.3.929 · Cited by 100
Cited by
The Sympathetic Nervous System in Heart Failure
Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.015 · Cited by 978
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Self-citationNitric Oxide and Cardiac Function: Ten Years After, and Continuing
Massion, P. B., Feron, O., Dessy, C., & Balligand, J.-L. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 567
Self-citationEndogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes
Petroff, M. G. V., Kim, S. H., Pepe, S., Dessy, C., Marbán, E., Balligand, J.-L., & Sollott, S. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-867 · Cited by 329
Self-citationPaolocci, N., Katori, T., Champion, H. C., St. John, M. E., Miranda, K. M., Fukuto, J. M., Wink, D. A., & Kass, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937302100 · Cited by 315
Metadata
- Authors
- Moniotte, S., Kobzik, L., Feron, O., Trochu, J.-N., Gauthier, C., & Balligand, J.-L.
- Venue
- Circulation
- Published
- 2001-03-27
- Volume
- 103
- Issue
- 12
- Pages
- 1649-1655
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1984401650
- Cited by
- 328
- References
- 31
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.